Christi Shaw says she made the move from Eli Lilly and Co.'s drug division to CEO of Gilead Sciences' Kite Pharma to focus on CAR T-cell therapies, which her sister received before her death from multiple myeloma. Shaw said she wanted to do something transformational, but she will face challenges because CAR T cells have not yet lived up to expectations.
Capricor Therapeutics reported promising mid-stage results from an ongoing clinical trial of a cell-based therapy that strengthens skeletal muscles and pulmonary and cardiac function in people with Duchenne muscular dystrophy. Cofounder and CEO Linda Marban says Capricor executives will meet with FDA officials soon to discuss a Phase III trial and said the company is considering options for bolstering its financial position and may seek equity financing, a private placement or NIH grants.
GlaxoSmithKline CEO Emma Walmsley is taking a different path than executives at some rival drug firms, divesting experimental drugs, replacing most of her top managers, cutting some 3,800 employees, and entering a joint venture with Pfizer for consumer products. Walmsley is boosting GSK's oncology pipeline and carefully selecting potentially lucrative opportunities rather than large takeovers as she works to achieve a culture shift.
Respira Labs founder Maria Artunduaga is among the 40 Silicon Valley entrepreneurs younger than 40 gaining recognition for career growth and community contributions. Artunduaga is a longtime advocate for inclusivity in STEM, participates in Association for Women in Science mentorship programs and has been lobbying for a ministry of science and technology in her native Colombia.
European Commission President Ursula von der Leyen, the first woman to lead the EU's executive branch, says climate change is at the top of her agenda and will announce a so-called Green Deal for Europe that includes a biodiversity strategy, an extended emissions-trading system and a carbon leakage tax. Von der Leyen will need to gain the support of EU member states to implement her climate agenda.
Women with mild cognitive impairment had more diffuse and scattered tau networks associated with Alzheimer's disease, indicating more affected brain areas, compared with men with MCI, researchers reported at the annual meeting of the Alzheimer's Association. Other studies showed better brain metabolism and prolonged maintenance of normal verbal performance among women with Alzheimer's symptoms, which may delay Alzheimer's diagnosis for women, while four genes were found that were associated with Alzheimer's risk for one sex but not the other.
Seventy percent of working women responding to a 2017 women's leadership survey said it's important to help more women advance in the workplace, but only a third said they know how to support their fellow female employees. Female executives can help by starting or advocating for an executive mentorship program and a women's employee resource group, and ensuring women are included in the company's succession planning, writes Janice Lopez, managing director of entrepreneurial services at WBC Chicago and the Women's Business Development Center.
Whether or not hugging is acceptable varies by industry, region and rank at work, say workplace etiquette experts. They offer alternate ways of expressing warmth if a person's body language signals too much contact is unwelcome.
Science is uncertain and its pursuit is prone to failure, but scientists shouldn't take failure personally, says neuroscientist Miriam Goodman, deputy director of the Stanford Neuroscience Institute. Goodman as well as two postdoctoral fellows and two graduate students in her lab discuss their work and what paths they might take.
Science fairs and Olympiads are common gateways to STEM careers for students, but research suggests boys and girls can have very different experiences at these events, Sarah White writes. Girls tend to favor projects in biology or that are socially conscious, while boys lean toward projects that are more abstract and in the physical sciences, White notes.
Becoming an executive is no easy task. Becoming a female executive is something else altogether. How can the ambitious woman excel, advance and thrive in seemingly male-dominated industries with thousands of years of history working against her? Through her own inspiring journey from employee to powerful female executive, Robin Toft couples the wisdom she gleaned at the boardroom table as an executive with over a decade of experience in executive search as Founder and CEO of the award-winning Toft Group. Get more information or register.
Women In Bio congratulates Jane Gross, Ph.D., for joining the Board of Directors at aTyr Pharma. Jane was a member of the 2017 Boardroom Ready class. A big congratulations also goes out to Karah Parschauer, Boardroom Ready 2018 alumna, for her two recent appointments to the Board of Directors for Arcturus Therapeutics and Evolus Aesthetic. Learn more.